Balchem Corporation BCPC
At closeNov 3, 2026, 4:00 PM EST
After hours · Nov 3, 4:00 PM ET
- YTD
- +14.44%
- 1 year
- +15.07%
- Market cap
- 5.59B
- Revenue (ttm)
- 1.11B
- Profit margin
- 15.41%
- EPS (ttm)
- 5.30
- Shares out
- 31.88M
- P/E ratio
- 33.12
- Forward P/E
- 27.58
- Dividend
- 0.96 (0.55%)
- Ex-dividend date
- Dec 22, 2025
- YTD return
- +14.44%
- 1-year return
- +15.07%
- Volume
- 319.29K
- Avg volume
- 229.01K
- Open
- 174.60
- Previous close
- 174.60
- Day's range
- 172.56 – 178.24
- 52-week range
- 147.18 – 183.90
- Beta
- 0.85
- Analysts
- Buy
- Price target
- 213.50 (+21.6%)
- Earnings date
- Feb 19, 2027
2Y +3.05 (+1.77%)
Key statistics
- Enterprise value
- 5.62B
- PEG ratio
- 3.36
- Price / sales
- 5.05
- Price / book
- 4.21
- Dividend yield
- 0.55%
- Payout ratio
- 18.11%
- Revenue growth
- 8.60%
- Free cash flow
- 139.50M
- Total cash
- 66.26M
- Total debt
- 142.44M
- Return on equity
- 13.02%
- Short % of float
- 2.23%
- 50-day average
- 170.04
- 200-day average
- 169.31
Analyst view
Consensus: buy
- Target (low)
- 175.00
- Target (mean)
- 213.50
- Target (high)
- 254.00
- Strong buy1
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 19, 2027
Expected Feb 19, 2027. Consensus EPS estimate 1.47.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 19, 2027 | Dec 30, 2026 | 1.41 | — | — | — |
| Oct 23, 2026 | Sep 30, 2026 | 1.43 | 1.57 | +0.14 | +9.79% |
| Jul 31, 2026 | Jun 30, 2026 | 1.27 | 1.40 | +0.13 | +10.24% |
| Apr 30, 2026 | Mar 31, 2026 | 1.33 | 1.25 | -0.08 | -6.02% |
| Feb 20, 2026 | Dec 31, 2025 | 1.29 | 1.31 | +0.02 | +1.55% |
| Oct 21, 2025 | Sep 30, 2025 | 1.36 | 1.35 | -0.01 | -0.74% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 23, 2026 | HC Wainwright & Co. | main | Buy | Buy |
| Aug 3, 2026 | HC Wainwright & Co. | main | Buy | Buy |
| May 4, 2026 | HC Wainwright & Co. | main | Buy | Buy |
| Feb 24, 2026 | HC Wainwright & Co. | main | Buy | Buy |
| Dec 5, 2025 | Rothschild & Co | init | — | Neutral |
| Oct 22, 2025 | HC Wainwright & Co. | main | Buy | Buy |
About Balchem Corporation
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Country
- United States
- Website
- balchem.com
News
Balchem Corporation to Participate in Baird's Global Industrial Conference on November 11, 2026 
3 Companies With Room to Pass on Costs to Manage Inflation 
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $210 
Balchem: Record Sales, Great Fundamentals, Priced Fully, Hold 
Balchem: 3 Key Takeaways for Long-Term Investors 
Balchem Corporation (BCPC) Q3 2026 Earnings Call Transcript 
Balchem Q3 2026 Earnings Call Transcript 
Balchem Q3 Adj. EPS $1.57 Beats $1.53 Estimate, Sales $290.658M Beat $289.250M Estimate 
Balchem Corporation Reports Third Quarter 2026 Financial Results 
American Express, Eni On Deck Friday As Spending, Energy Demand Face Test
Your note
Sign in to keep a note on BCPC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BACKUS WILLIAM A | Officer | Stock Award(Grant) | Feb 10, 2026 | 7,019 |
| BENGTSSON CARL MARTIN | Chief Financial Officer | Stock Award(Grant) | Feb 10, 2026 | 29,012 |
| BONED FREDERIC | Officer | Stock Award(Grant) | Feb 10, 2026 | 9,419 |
| FISCHER DAVID B | Director | Stock Award(Grant) | Feb 10, 2026 | 8,859 |
| HARRIS THEODORE L | Chief Executive Officer | Stock Award(Grant) | Feb 10, 2026 | 94,402 |
| MIYATA HATSUKI | Officer | Stock Award(Grant) | Feb 10, 2026 | 9,232 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.62% | 4,964,479 | 871.32M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.99% | 2,221,267 | 389.85M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.55% | 1,445,369 | 253.68M | Jun 29, 2026 |
| State Street Corporation | 4.03% | 1,281,552 | 224.93M | Jun 29, 2026 |
| Geode Capital Management, LLC | 3.53% | 1,122,146 | 196.95M | Jun 29, 2026 |
| Conestoga Capital Advisors, LLC | 2.69% | 854,550 | 149.98M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.98% | 1,898,724 | 333.25M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.21% | 1,018,611 | 178.78M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.65% | 842,214 | 147.82M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.32% | 737,004 | 129.35M | Jun 29, 2026 |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 1.81% | 574,500 | 100.83M | Sep 29, 2026 |
| Conestoga Funds-Conestoga Small Cap Fund | 1.60% | 508,950 | 89.33M | Jun 29, 2026 |